Scientific ReportsNeurosciencePeer-reviewed journal article
Evaluating analgesic efficacy and administration route following craniotomy in mice using the grimace scale
Chulmin ChoiD, Vassilia MichailidisiD, Irene Lecker, Chereen Collymore, David Hanwell, Mary Loka, Matthew Danesh, Christine Pham, Paige Urban, Robert P. BoniniD, Loren J. MartiniD
Abstract
Most research laboratories abide by guidelines and mandates set by their research institution regarding the administration of analgesics to control pain during the postoperative period. Unfortunately, measuring pain originating from the head is difficult, making adequate decisions regarding pain control following stereotaxic surgery problematic. In addition, most postsurgical analgesia protocols require multiple injections over several days, which may cause stress and distress during a critical recovery period. Here we sought to 1) assess the degree of postoperative pain following craniotomy in mice, 2) compare the efficacy of three common rodent analgesics (carprofen, meloxicam and buprenorphine) for reducing this pain and 3) determine whether the route of administration (injected or self-administered through the water supply) influenced pain relief post-craniotomy. Using the mouse grimace scale (MGS), we found that injectable analgesics were significantly more effective at relieving post-craniotomy pain, however, both routes of administration decreased pain scores in the first 24 h post-surgery. Specifically, buprenorphine administered independently of administration route was the most effective at reducing MGS scores, however, female mice showed greater sensitivity to carprofen when administered through the water supply. Although it is necessary to provide laboratory animals with analgesics after an invasive procedure, there remains a gap in the literature regarding the degree of craniotomy-related pain in rodents and the efficacy of alternative routes of administration. Our study highlights the limitations of administering drugs through the water supply, even at doses that are considered to be higher than those currently recommended by most research institutions for treating pain of mild to moderate severity.
- Citations
- 59
- FWCI
- 9.58
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Subcutaneous and orally self-administered high-dose carprofen in male and female mice: pharmacokinetics, tolerability and impact on cage-side pain indicators
A. Glasenapp, J. P. Bankstahl, … M. Bankstahl·bioRxiv·Jun 3, 2023
- A Buprenorphine depot formulation provides effective sustained post-surgical analgesia for 72h in mouse femoral fracture models
A. Wolter, C. H. Bucher, … A. Lang·bioRxiv·Jul 5, 2022
- GrimACE: Automated, multimodal cage-side assessment of pain and well-being in mice
Oliver Sturman, Marcel Schmutz, … Johannes Bohacek·Lab AnimalPeer-reviewed·Mar 5, 2026
- Comparing the Rat Grimace Scale and a composite behaviour score in rats
C. Klune, A. Larkin, … D. S. Pang·bioRxiv·Dec 7, 2018
- Metabolic Cage Analysis of Surgically Catheterized C57Bl/6J Mice (Mus musculus) Treated with Carprofen and Sustained-release Buprenorphine
Jui Rose Tu, Marissa Saenz, … Patrick T. Fueger·Journal of the American Association for Laboratory Animal SciencePeer-reviewed·Nov 1, 2025
- Intraperitoneal injection of sodium pentobarbital is associated with pain in rats.
J. Reimer, C. Schuster, … V. S. Leung·bioRxiv·Jul 15, 2019